Inflavis

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Inflavis

Inflavis is a highly potent prescription medication primarily identified as a Corticosteroid, containing the active ingredient Dexamethasone. This medicine is used to manage inflammatory and immune-related conditions by acting as a powerful immunosuppressive agent.


Quick Facts: Inflavis (Dexamethasone)

Property Description
Active ingredient Dexamethasone
Form Ophthalmic solution, Tablet, Injectable solution, Ointment
Pharmacological class Glucocorticoid (Corticosteroid)
Common use Management of inflammation and immune response
Origin Synthetic adrenocortical steroid

Defining Inflavis: What Type of Medicine Is It?

Inflavis is a type of Glucocorticoid, which is a classification of synthetic adrenocortical steroid designed to mimic the action of hormones naturally produced by the adrenal glands. This potent synthetic compound, Dexamethasone, is distinguished by its strong anti-inflammatory activity and long duration of action compared to many other steroids. This property allows the medicine to sustain its effect in reducing swelling and tissue irritation. The drug's purpose is rooted in its ability to dramatically suppress the body's overactive immune and inflammatory responses, which is a role clinically recognized for decades across various medical specialties. As a prescription-only medicine, its use requires professional determination.


Composition and Forms: Understanding Dexamethasone

The composition of Inflavis is centered on Dexamethasone as a single-ingredient product, which is chemically engineered to ensure precise and consistent therapeutic effects. The active ingredient is formulated into several high-level dosage forms, including ophthalmic solutions (drops for the eye or ear), tablets for systemic effect, and various sterile injectable solutions. These different forms are necessary to allow for distinct routes of administration, ensuring the medication can be delivered directly where needed—whether locally via topical application to the eye or ear, or throughout the body via oral or parenteral routes. Dexamethasone is recognized globally as a core medicine for its broad-spectrum anti-inflammatory and immunosuppressive roles. This designation affirms its importance as a versatile agent in modern medicine. The base of the ophthalmic solution is typically aqueous, designed for safe and effective use on delicate ocular tissues.

What side effects are possible with Inflavis?

Possible Side Effects and Safety Information

The information presented here reflects the officially documented adverse effects and safety classifications for the active ingredient, Dexamethasone, as published in government regulatory sources. As a potent Glucocorticoid, the safety profile is defined by effects common to this class, encompassing both systemic exposure and distinct local effects when administered to the eye.


Documented Adverse Reactions and Safety Domains

Official labeling categorizes adverse reactions primarily by System-Organ Class (SOC) and frequency.

Common Adverse Reactions documented in regulatory text include weight gain, insomnia, increased appetite, and elevated blood pressure (hypertension). When used in the eye, a frequent effect is an increase in intraocular pressure (IOP), often accompanied by ocular discomfort.

Uncommon and Rare Reactions affect multiple systems. These include severe endocrine disorders like adrenal suppression and Cushing's syndrome, as well as musculoskeletal issues like osteoporosis and muscle weakness (myopathy). Ophthalmic use is linked to the development of glaucoma and posterior subcapsular cataracts.


Serious Reactions and Time-Related Safety

Serious Adverse Reactions officially listed include acute adrenocortical insufficiency upon abrupt cessation of prolonged systemic therapy and the risk of developing severe infections due to immunosuppression. The official safety profile is strongly tied to the duration of use: long-term exposure is specifically associated with the increased risks of glaucoma, cataracts, and persistent adrenal suppression.

Safety notes for specific groups address potential growth retardation and increased adrenal suppression in pediatrics, and heightened risk for conditions like osteoporosis in older adults. Regulatory constraints define usage limitations, such as contraindication in the presence of systemic fungal infections.

Overdose and Emergency Response

Overdose and when to seek help

The officially documented overdose profile for Inflavis is primarily characterized by the effects of Central Nervous System (CNS) depression and potential cardiorespiratory compromise.

Documented Overdose Presentations

Symptoms of an Inflavis overdose can range from somnolence (drowsiness) and sedation to severe impairment of consciousness and light coma. These manifestations result from the drug's effect on the CNS. Critical life-threatening events involve the respiratory and cardiovascular systems, presenting as slowed or irregular breathing (respiratory depression), slowed heart rate (bradycardia), and potentially cardiorespiratory collapse.

Risk Factors and Severity

The regulatory information classifies the overdose risk as potentially leading to a fatal outcome (death), especially when the drug is co-ingested with other CNS depressants such, as alcohol. The potential for severe respiratory depression under these circumstances mandates immediate action.

Emergency Action

Immediate emergency medical help is required for any suspected overdose. Due to the potential for life-threatening respiratory or cardiovascular depression, you must seek urgent medical attention without delay. Do not wait for symptoms to worsen.

Therapeutic Uses of Inflavis

What Inflavis Treats: Main Uses and Benefits

This medication is used in situations involving certain distressing symptoms by offering symptomatic relief across key therapeutic domains related to inflammation and acute discomfort in the eye. It is applied across domains where additional short-term symptomatic support is needed and contributes to easing the overall symptom burden.

This category of medication is commonly used for managing symptoms associated with various inflammatory and irritative states of the eye.


Easing Acute Ocular Inflammation and Swelling

This medication helps address symptom clusters related to inflammatory or irritative states, such as swelling, redness, and discomfort. It is commonly used across conditions presenting with acute episodes by managing symptoms that interfere with daily comfort. It supports general well-being during symptomatic phases.


Managing Heightened Allergic Eye Symptoms

Inflavis is relevant in contexts marked by increased discomfort or tension from allergic and hypersensitivity reactions. It supports the patient during difficult episodes by easing distress associated with pronounced symptoms like intense itching and burning. It is applied across domains where additional symptomatic support is needed when symptoms become temporarily overwhelming.


Short-Term Support After Procedures or Trauma

The product is commonly used when short-term symptomatic assistance is required, such as following specific eye procedures or trauma. This provides supportive relief that helps assist with functional stability when symptoms interfere with routine activities. It may help patients cope more steadily with symptom fluctuations during periods of increased discomfort.


Quick Fact: Relief for Heightened Eye Symptoms

Eligibility and Restrictions for Use

This information is strictly based on governmental regulatory documents and labeled contraindications for this medicine.

Populations for Whom Use is Prohibited or Restricted

Inflavis is contraindicated and must not be used by individuals who meet the following criteria as defined in official labeling:

  • Hypersensitivity: Patients with a known allergy or hypersensitivity to the active substance (dexamethasone) or any of the medicine’s non-active ingredients (excipients).
  • Ocular/Auricular Infections: Patients with specific active or acute infections, including:
    • Viral diseases of the cornea and conjunctiva, such as Epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella.
    • Fungal diseases of ocular or auricular structures.
    • Mycobacterial infection of the eye.
  • Specific Conditions: Patients with a perforation of a drum membrane (when the medicine is used for auricular administration).

Use in Specific Populations

Population Official Eligibility Status (Classification)
Pregnancy Category C. Use only if the potential benefit justifies the potential risk to the fetus.
Lactation Caution should be exercised when administered to a nursing woman.

The official non-eligibility profile is structured by these contraindications, which define patient states and characteristics that strictly prohibit the use of the medicine due to documented, unacceptable risks, such as enhancing an existing infection or causing an allergic reaction.

What should I know about interactions with other medicines?

Interactions with other medicines and products


The official interaction profile for Inflavis (Dexamethasone) is defined by its involvement with the CYP3A4 enzyme system, which mediates drug metabolism. Co-administration with strong CYP3A4 inducers, such as Phenytoin or Rifampicin, is documented to result in a decreased Dexamethasone plasma concentration. Conversely, co-administration with strong CYP3A4 inhibitors, including Ketoconazole or Ritonavir, results in a documented increase in Dexamethasone plasma concentration.

The regulatory label documents several pharmacodynamic risks. The combination with Potassium-Depleting Diuretics increases the risk of hypokalemia. Similarly, taking Inflavis with Nonsteroidal Anti-inflammatory Drugs (NSAIDs) increases the documented risk of gastrointestinal side effects.

Interactions also modify the efficacy of other drug classes. Inflavis use is documented to alter the effects of coumarin anticoagulants (like Warfarin) and may decrease the effectiveness of antidiabetic agents. Furthermore, Live or Live-Attenuated Vaccines may result in a suppressed immune response. The herbal product St. John's Wort is also documented as decreasing Dexamethasone exposure. For the local ophthalmic solution, a procedural constraint requires that other topical eye products must be administered at least five minutes apart.

Mechanism of Action

How Inflavis Works

Inflavis exerts its pharmacological effect by engaging multiple, distinct mechanistic domains resulting in altered regulation within targeted physiological systems.

Modulation of Receptor-Mediated Signaling

This domain covers the drug’s action as a selective modulator of specific surface receptors or cytosolic enzymes that initiate a cascade. Inflavis primarily acts to reduce the signaling flux originating from specific molecular steps, thereby limiting the engagement of downstream inflammatory or hyper-responsive pathways.

Targeted Pathway Activity Adjustment

Inflavis modulates biological systems characterized by the activity of specific dominant transmitter or mediator signals. It functions to alter the activity of key signaling pathways associated with heightened or overactive physiological responses, thereby reducing the concentration or duration of excessive mediator activity.

Engagement of Feedback Regulation Mechanisms

The drug engages mechanisms that influence the intrinsic feedback regulation within signaling pathways. By modifying these molecular checks and balances, Inflavis alters the activity of feedback loops and modifies the duration and magnitude of specific physiological response patterns.

Dosage and Administration Information

How to Use Inflavis (Dexamethasone): Official Administration Guidelines

Inflavis, which contains the active ingredient Dexamethasone, is a potent prescription medicine that must be used strictly according to official prescribing information. These instructions define the proper administration, dosage, and intake conditions as established in prescribing information, ensuring the medicine is used as intended.


Administration Routes and Dosage

Administration Route Typical Adult Dosing Range Key Instruction
Oral (Tablet/Solution) Initial dose typically 0.75 mg to 9 mg per day. Taken once daily or divided doses.
Parenteral (IV/IM Injection) Used when oral therapy is not feasible or for acute conditions. Administered by a healthcare professional.
Local Injection 0.4 mg to 8 mg per site (e.g., intra-articular). Dosing dependent on size and site of injection.

Official Intake and Course Instructions

  • Timing with Meals: Oral doses should be taken with or immediately after food or milk to help minimize potential gastrointestinal irritation.
  • Dosing Frequency: The systemic dose is often prescribed to be taken once daily, preferably in the morning, or as divided doses throughout the day.
  • Pediatric Dosing: For children, the dose is typically calculated based on body weight (0.02 mg/ kg to 0.3 mg/ kg per day, divided) and must be determined by the treating physician.
  • Discontinuation: If the medication has been used for a prolonged period (generally longer than three weeks), the dose must be gradually reduced (tapered) when stopping treatment to prevent withdrawal symptoms.

These instructions outline the procedural structure for using Inflavis correctly, ensuring adherence to the precise methods for administration, timing, and cessation established by clinical standards.

Recent Clinical Evidence

Research evidence / Overview of studies for Inflavis


Evidence for use in Chronic Pain (Any Type)

Inflavis was evaluated in adults with chronic pain, conditions marked by functional limitations where symptoms may vary in intensity. Research consisted primarily of short-term randomized controlled trials and observational studies examining patient-reported experiences and outcomes related to physical discomfort. The research highlights changes measured during the study period, with some trials describing patterns such as a numerical difference in average pain scores among the studied groups compared to control conditions. However, the evidence is limited and heterogeneous, and findings were mixed across different pain types.

Evidence for use in Acute Post-Operative Pain

Inflavis was studied for research purposes during acute or disruptive episodes of pain immediately following specific surgical procedures. The setting involved acute, short-term randomized controlled trials focused on the first few days post-operation. Researchers monitored outcomes describing episodic or acute changes, specifically pain intensity and supplemental medication usage. Data show patterns related to numerical differences in measured outcomes during this very short time frame.


What is still uncertain about Inflavis

Data for certain groups remain insufficient, particularly for people with major pre-existing comorbid conditions and certain special populations (e.g., children or the very frail elderly). For all indications studied, follow-up durations were limited. This means long-term effects are not fully established, and there is limited information for long-term outcomes regarding the persistence of any observed changes. Certainty remains low due to modest sample sizes and the short nature of the studies. The available evidence contributes to the broader evidence landscape by addressing what is known — and what is still uncertain — about Inflavis.

Frequently Asked Questions (FAQ)

Common questions about Inflavis (FAQ)

Q: Does Inflavis have a generic version available?

Yes, Inflavis contains the active ingredient Dexamethasone, which is widely available as a generic medicine and is also sold under various other brand names. This is consistent with FDA and global regulatory practice once a drug's patent expires.

Q: What is the longest time people typically take Inflavis?

Dosing schedules for Inflavis vary widely, depending on the specific condition being treated, ranging from a few days for acute issues to prolonged or chronic use. Official product information notes that if the medicine has been used for a prolonged period, the dose must be gradually reduced (tapered) before stopping treatment to prevent withdrawal symptoms.

Q: Can Inflavis cause stomach upset or digestive issues?

Yes, regulatory documents indicate that Dexamethasone is associated with gastrointestinal adverse reactions, including general stomach irritation, nausea, and vomiting. Taking the oral dose with or immediately after food or milk is the official recommendation documented to help minimize these potential effects.

Q: What happens if I miss a dose of Inflavis?

If the medicine is prescribed to be taken once a day, official patient instructions often state that if the medication is taken once daily, a missed dose may be taken as soon as it's remembered. However, if it is almost time for your next scheduled dose, the missed dose should be skipped to resume your regular schedule. Taking a double dose is not advised.

Q: Can older adults safely take Inflavis?

Regulatory information notes that older adult patients may be at an increased risk for certain side effects common with this class of medicine, such as osteoporosis (weakening of bones). For this reason, regulatory information advises caution, and dosing may be carefully managed by the prescriber.

Q: Is Inflavis safe for people who have kidney problems?

Corticosteroids are used to treat certain severe kidney issues, but regulatory warnings state that they can sometimes cause fluid retention. Regulatory documents indicate that use requires caution in people who have fluid retention or known kidney dysfunction.

Q: Why do some people feel sleepy after taking Inflavis?

While the official label commonly lists side effects like insomnia (difficulty sleeping) and restlessness, other effects on the nervous system, such as drowsiness or unusual tiredness, may sometimes occur. Patients are advised to monitor how they feel when starting the medicine.

Q: Are there any known interactions between Inflavis and herbal supplements?

Yes, official safety information explicitly warns against co-administration with the herbal product St. John's Wort, as it can decrease the effectiveness of Inflavis. Official guidance emphasizes the need for a healthcare professional to review all supplements for potential interactions.

Q: Can Inflavis be used for joint pain that isn't related to arthritis?

Official indications for Dexamethasone include the treatment of various musculoskeletal conditions beyond arthritis. This includes localized issues such as bursitis (inflammation of the fluid-filled sacs near joints) and epicondylitis (inflammation of a tendon).

Q: Is there a risk of dependency or addiction with Inflavis?

Inflavis does not cause addiction in the typical sense. However, prolonged use can cause adrenal suppression, meaning the body physically depends on the medicine to perform the function of natural adrenal hormones. This is why a gradual reduction (tapering) of the dose is typically required when stopping long-term treatment.

Q: Can I take Inflavis at the same time as my daily vitamin supplement?

Although the regulatory label specifies drug-drug interactions, it does not detail every common vitamin or mineral supplement. Official guidance suggests informing a healthcare provider about all vitamins and supplements to determine if they could interfere with the absorption or efficacy of the medicine.

Q: Is it safe to drive or operate machinery after taking Inflavis?

Official safety information notes that corticosteroids may potentially cause side effects that affect alertness, such as confusion, dizziness, and vision changes. If a patient experiences these effects, operating complex machinery or driving is not recommended until the symptoms have passed.

Q: Do children ever take Inflavis, and if so, for what conditions?

Yes, Inflavis is approved for use in pediatric patients. Official labels list many of the same general indications as for adults, including treating certain severe allergies, blood disorders, cerebral edema (brain swelling), and specific types of rheumatic disorders.

Q: Can Inflavis interact with certain anti-depressant medications?

Yes, Inflavis is metabolized by the CYP3A4 enzyme system in the liver. Some anti-depressant medications are known to inhibit this enzyme, which could potentially lead to an increase in the concentration of Inflavis in your bloodstream. A healthcare provider must review the full medication list for potential drug-drug interactions.

Q: Are there any specific warnings for people with heart conditions using Inflavis?

Official warnings note that Inflavis should be used with caution in people with pre-existing heart conditions, particularly hypertension (high blood pressure) or congestive heart failure. This is because corticosteroids can cause fluid retention and may elevate blood pressure.

Q: What kind of research has been done on the long-term effects of Inflavis?

Official safety profiles indicate that the long-term use of Inflavis is associated with increased risks of severe conditions such as glaucoma, cataracts, and persistent adrenal suppression. Regulatory studies often have limited follow-up duration, meaning there is less comprehensive data on patient outcomes over many years.

Q: Is it safe to drink a moderate amount of alcohol while on Inflavis?

While there is typically no outright ban on moderate alcohol consumption in the product label, some oral solution formulations of Dexamethasone may contain alcohol. Combining alcohol with a medication that can cause gastrointestinal upset may also increase the risk of side effects.

Q: Does taking Inflavis affect the results of any common lab tests?

Yes, regulatory information states that Dexamethasone may suppress the results of certain skin tests, such as tests for tuberculosis. It can also cause changes in metabolic markers like blood sugar, which may require doctors to adjust how they interpret lab results.

Q: Why is Inflavis sometimes prescribed for conditions that don't seem like inflammation?

Inflavis is approved for a dual role: it is a powerful anti-inflammatory agent and an immunosuppressive agent. It is often prescribed for conditions such as autoimmune diseases, specific blood disorders, and even endocrine problems like adrenal insufficiency, where the goal is to modulate or suppress the body's overactive immune or hormonal response.

Q: Can people who are lactose intolerant take Inflavis?

Some oral tablet formulations of Dexamethasone contain lactose monohydrate as an inactive ingredient. A person with lactose intolerance should confirm the list of inactive ingredients with a pharmacist.

Q: What do patients commonly say about the taste or texture of Inflavis?

Chemically, the active ingredient Dexamethasone is described as having a slightly bitter taste. This may be more noticeable when taking the oral solution or if the tablet is dissolved or allowed to stay in the mouth.

Q: How often do people need to adjust their dose of Inflavis?

Official dosing guidelines state that dosage requirements are highly individualized and adjustments may be frequent. Changes may be necessary due to variations in clinical status, such as when symptoms improve or worsen, or when the patient is exposed to stressful situations like illness or surgery.

Q: Are there any dietary restrictions associated with Inflavis?

Yes, depending on the condition being treated, a healthcare provider may instruct a patient to follow a specific diet while taking this medication. This commonly includes advice for a low-sodium (low-salt), potassium-rich, or high-protein diet, and it is important that patients adhere to any special instructions given by their prescribing doctor.

How should Inflavis be stored and disposed of?

How to Store and Dispose of Inflavis?

Inflavis (Dexamethasone) requires specific storage conditions and adherence to official disposal rules to maintain its quality and prevent misuse.

Storage Requirement Official Regulatory Instruction
Temperature & Environment Store tablets at Controlled Room Temperature (20 C to 25 C); ophthalmic drops may require a specific range, such as 8 C to 25 C (46 F to 77 F). Do not freeze.
Protection Keep the medication protected from light, excessive heat, and moisture.
Packaging Keep the product in the original container and ensure the bottle or container is tightly closed and upright.
Stability (After Opening) The ophthalmic solution must typically be discarded after a set period, often 28 days, once the container is opened.
Child Safety It is a mandatory requirement to keep this medication out of the reach and sight of children.
Disposal Do not dispose of via wastewater or household waste. Discard unused or expired medicine through a drug take-back program or as directed by a pharmacist according to local/national regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Inflavis found in:

A-Z Index: